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Inclusion criteria 
Studies:  
Randomized and quasi-randomized controlled trials. 
Participants: 
People diagnosed with dengue shock syndrome. 
Intervention: 
Corticosteroids compared with placebo or no 
corticosteroids. 
Outcomes: 
Primary: death. 
Adverse events: any adverse events. 
Results 
• Four randomized controlled trials involving 284 
participants, all under the age of 15 years, were 
included. No trials described allocation 
concealment. 
• All four trials (284 participants) had death as an 
outcome. There was no significant difference 
between the corticosteroid and comparison groups; 
however, the number of deaths was small in all 
groups. 
• There was no significant difference between groups 
in the numbers of participants needing blood 
transfusion (2 trials, 89 participants), severe 
complications (1 trial, 63 participants), or days in 
hospital (1 trial, 63 participants).   
 
Do corticosteroids improve survival in people 
with dengue shock syndrome? 
There is no good evidence that corticosteroids improve survival 
in patients with dengue shock syndrome. 
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Authors’ conclusions 
Implications for practice:  
There is not enough evidence to justify using corticosteroids in dengue shock syndrome. 
Implications for research: 
Large, good quality randomized controlled trials of corticosteroids for people with dengue shock syndrome are 
needed.  
The Cochrane Database of Systematic Reviews is available from www.wiley.com, and free for eligible countries through www.healthinternetwork.org.  
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